Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
The Centers for Vulvovaginal Disorders (CVVD) is a specialized medical practice and clinical research center dedicated to the diagnosis and treatment of chronic vulvar and vaginal pain conditions. Founded in 2001 by Dr. Andrew Goldstein, the center operates clinics in Washington, D.C., New York City, and Tampa, serving as a global referral hub for complex gynecological cases. CVVD is a leader in clinical research within the field of female sexual medicine, having published over 100 peer-reviewed studies on conditions such as vulvodynia and lichen sclerosus. The center utilizes a multidisciplinary approach that includes medical, surgical, and physical therapy interventions. Its work has significantly advanced the medical community's understanding of the pathophysiology and treatment of vestibulodynia and other vulvovaginal disorders.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on The Centers for Vulvovaginal Disorders.